|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$1.11 |
$1.20 |
$1.08 |
$1.17 |
3.70K | 04/22/2024 |
$1.13 |
$1.22 |
$1.13 |
$1.18 |
13.90K | 04/23/2024 |
$1.13 |
$1.23 |
$1.13 |
$1.21 |
4.90K | 04/24/2024 |
$1.21 |
$1.21 |
$1.17 |
$1.19 |
7.50K | 04/25/2024 |
$1.20 |
$1.20 |
$1.17 |
$1.19 |
3.90K |
|
Akari Therapeutics is a clinical-stage biopharmaceutical company focused on developing treatments for acute and chronic inflammation, specifically through the inhibition of the complement (C5) and leukotriene pathways. Co.'s primary product candidate, nomacopan, inhibits both terminal C5 activation and leukotriene B4 (LTB4). Co.'s clinical targets for nomacopan are orphan inflammatory diseases where the inhibition of both C5 and LTB4 are implicated, including bullous pemphigoid, pediatric hematopoietic stem cell transplant-associated thrombotic microangiopathy, and as well as inflammatory conditions in the eye and lung including dry eye, dry AMD and COVID-19 pneumonia. | |
|
Akari Therapeutics PLC (AKTX) has the following price history information. Looking back at AKTX historical stock prices for the last five trading days, on April 19, 2024, AKTX opened at $1.11, traded as high as $1.20 and as low as $1.08, and closed at $1.17. Trading volume was a total of 3.70K shares. On April 22, 2024, AKTX opened at $1.13, traded as high as $1.22 and as low as $1.13, and closed at $1.18. Trading volume was a total of 13.90K shares. On April 23, 2024, AKTX opened at $1.13, traded as high as $1.23 and as low as $1.13, and closed at $1.21. Trading volume was a total of 4.90K shares. On April 24, 2024, AKTX opened at $1.21, traded as high as $1.21 and as low as $1.17, and closed at $1.19. Trading volume was a total of 7.50K shares. On April 25, 2024, AKTX opened at $1.20, traded as high as $1.20 and as low as $1.17, and closed at $1.19. Trading volume was a total of 3.90K shares.
AKTX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Akari Therapeutics PLC shares, starting with a $10,000 purchase of AKTX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$122.00 |
|
End price/share: |
$1.19 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.02% |
|
Average Annual Total Return: |
-37.07% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$97.53 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/19/2024 | $1.17 | 04/22/2024 | $1.18 | 04/23/2024 | $1.21 | 04/24/2024 | $1.19 | 04/25/2024 | $1.19 |
|
|